Paul D. Thompson MD
Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, ConnecticutPaul D. Thompson, MD, graduated from Tufts College and from Tufts Medical School. He served as a medical intern and resident at Tufts New England Medical Center and completed his training in cardiology at Stanford Medical Center.
Dr. Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992. He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors, the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function, and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of Coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia. Dr. Thompson is the Co-Editor of the book Exercise and Sports Cardiology and of the book Statin Associated Muscle Symptoms. He is a Past President of the American College of Sports Medicine.
Disclosures
Paul D. Thompson, MD, has received research support from Esperion and Norvartis; owns stock in Abbott Labs, CVS, Ilumina, Novo-Nordisk, GE Healthcare, Johnson & Johnson, Medtronic, Opsens, SCPharmaceuticals, Sarepta and Shockwave Medical; and has provided legal consultation on exercise-related cardiac events and statin myopathy.
Recent Contributions to PracticeUpdate:
- Relationship Between Physical Activity, Sedentary Time, and Heart Failure Risk in Older Women
- ACC 2024: Recommendations From Dr. Paul Thompson
- Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
- Sex Differences With Benefit of Physical Activity With All-Cause and Cardiovascular Mortality
- Occupational Sitting Time, Leisure Physical Activity, and All-Cause and CVD Mortality
- Aerobic, Resistance, or Combined Exercise Training and CV Risk Profile in Adults With Overweight or Obesity
- Association of Lp(a) Levels With Myocardial Fibrosis
- Resistance Training in Individuals With and Without CVD
- 2023 Top Story in Cardiology: Athletes With Potentially Dangerous Cardiac Conditions Returning to Sport
- Device-Measured Physical Activity and Cardiometabolic Health